Skip to Main content Skip to Navigation


...
hal-02088095v1  Journal articles
Elaine KingwellEmmanuelle LerayFeng ZhuJohn PetkauGilles Edan et al.  Multiple sclerosis: effect of beta interferon treatment on survival
Brain - A Journal of Neurology , Oxford University Press (OUP), 2019, 142 (5), pp.1324-1333. ⟨10.1093/brain/awz055⟩
...
hal-03223056v1  Journal articles
Izanne RoosEmmanuelle LerayFederico FrascoliRomain CaseyJ William L Brown et al.  Determinants of Therapeutic Lag in Multiple Sclerosis
Multiple Sclerosis Journal, SAGE Publications, 2021, 27 (12), pp.1838-1851. ⟨10.1177/1352458520981300⟩
hal-02437067v1  Journal articles
Gilles EdanEmmanuelle Leray. A new treatment era in multiple sclerosis: Clinical applications of new concepts
Journal of the Neurological Sciences, Elsevier, 2011, 306 (1-2), pp.170-172. ⟨10.1016/j.jns.2010.09.018⟩
hal-02470788v1  Journal articles
Emmanuelle LerayF. MamadouA. GuilleuxJonathan RouxOlivier Grimaud. Geographical variations in access to expert centers for multiple sclerosis in France
European Journal of Public Health, Oxford University Press (OUP): Policy B - Oxford Open Option D, 2019, 29 (Supplement_4), pp.80-80. ⟨10.1093/eurpub/ckz185.205⟩
hal-02929403v1  Journal articles
Izanne RoosEmmanuelle LerayFederico FrascoliRomain CaseyDana Horakova et al.  Identification of Therapeutic Lag in Multiple Sclerosis
Neurology, American Academy of Neurology, 2020, 94 (15)
...
hal-02470973v1  Journal articles
Julie HavasEmmanuelle LerayFabien RollotRomain CaseyLaure Michel et al.  Predictive medicine in multiple sclerosis: A systematic review
Multiple Sclerosis and Related Disorders, Elsevier, 2020, 40, pp.101928. ⟨10.1016/j.msard.2020.101928⟩